Tue, March 26, 2019
Mon, March 25, 2019
Fri, March 22, 2019
Thu, March 21, 2019
Wed, March 20, 2019
Tue, March 19, 2019
Mon, March 18, 2019

Charles Duncan Maintained (AXSM) at Buy with Increased Target to $25 on, Mar 21st, 2019

Charles Duncan of Cantor Fitzgerald, Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Increased Target from $16 to $25 on, Mar 21st, 2019.

Charles, nor any peers, have made any analyst calls on AXSM in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30